Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients-A Randomized Phase 2 Clinical Trial.

Journal of Clinical Medicine
Michael J BrownsteinCarolyn Drazinic

Abstract

SRX246 is a vasopressin (AVP) 1a receptor antagonist that crosses the blood-brain barrier. It reduced impulsive aggression, fear, depression and anxiety in animal models, blocked the actions of intranasal AVP on aggression/fear circuits in an experimental medicine fMRI study and demonstrated excellent safety in Phase 1 multiple-ascending dose clinical trials. The present study was a 3-arm, multicenter, randomized, placebo-controlled, double-blind, 12-week, dose escalation study of SRX246 in early symptomatic Huntington's disease (HD) patients with irritability. Our goal was to determine whether SRX246 was safe and well tolerated in these HD patients given its potential use for the treatment of problematic neuropsychiatric symptoms. Participants were randomized to receive placebo or to escalate to 120 mg twice daily or 160 mg twice daily doses of SRX246. Assessments included standard safety tests, the Unified Huntington's Disease Rating Scale (UHDRS), and exploratory measures of problem behaviors. The groups had comparable demographics, features of HD and baseline irritability. Eighty-two out of 106 subjects randomized completed the trial on their assigned dose of drug. One-sided exact-method confidence interval tests were used ...Continue Reading

References

Dec 1, 1982·Controlled Clinical Trials·W C Blackwelder
Aug 12, 2004·Neurology·UNKNOWN Huntington Study Group
Jan 20, 2007·Bioorganic & Medicinal Chemistry·Christophe D GuillonNeal G Simon
Jun 10, 2008·Recent Patents on CNS Drug Discovery·Neal G SimonGary A Koppel
Nov 19, 2008·BMC Neuroscience·Craig F FerrisNeal G Simon
Apr 9, 2014·Movement Disorders : Official Journal of the Movement Disorder Society·Rainer HoffmannCarsten Saft
Mar 6, 2016·Journal of the Neurological Sciences·Signe Marie Borch NielsenKnud Josefsen
Feb 11, 2018·Advances in Experimental Medicine and Biology·Rhia Ghosh, Sarah J Tabrizi

❮ Previous
Next ❯

Methods Mentioned

BETA
pregnancy
contraception

Clinical Trials Mentioned

NCT01088932

Software Mentioned

R
ExactCIdiff
NeuroNext

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.